ARDSLEY ADVISORY PARTNERS 13D and 13G filings for Marrone Bio Innovations, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-08 5:09 pm Purchase |
2021-12-31 | 13G | Marrone Bio Innovations, Inc. MBII |
ARDSLEY ADVISORY PARTNERS | 18,335,767 10.350% |
2,384,631 (+14.95%) |
Filing |
| 2021-02-12 5:19 pm Sale |
2020-12-31 | 13D | Marrone Bio Innovations, Inc. MBII |
ARDSLEY ADVISORY PARTNERS | 15,951,136 9.400% |
-1,164,139 (-6.80%) |
Filing |